P2X₇-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells
- PMID: 22185840
- DOI: 10.1152/ajpendo.00209.2011
P2X₇-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells
Abstract
The P2X₇ receptor is an ATP-gated cation channel expressed by a number of cell types, including osteoblasts. Genetically modified mice with loss of P2X₇ function exhibit altered bone formation. Moreover, activation of P2X₇ in vitro stimulates osteoblast differentiation and matrix mineralization, although the underlying mechanisms remain unclear. Because osteogenesis is associated with enhanced cellular metabolism, our goal was to characterize the effects of nucleotides on metabolic acid production (proton efflux) by osteoblasts. The P2X₇ agonist 2',3'-O-(4-benzoylbenzoyl)ATP (BzATP; 300 μM) induced dynamic membrane blebbing in MC3T3-E1 osteoblast-like cells (consistent with activation of P2X₇ receptors) but did not induce cell death. Using a Cytosensor microphysiometer, we found that 9-min exposure to BzATP (300 μM) caused a dramatic increase in proton efflux from MC3T3-E1 cells (∼2-fold), which was sustained for at least 1 h. In contrast, ATP or UTP (100 μM), which activate P2 receptors other than P2X₇, failed to elicit a sustained increase in proton efflux. Specific P2X₇ receptor antagonists A 438079 and A 740003 inhibited the sustained phase of the BzATP-induced response. Extracellular Ca²⁺ was required during P2X₇ receptor stimulation for initiation of sustained proton efflux, and removal of extracellular glucose within the sustained phase abolished the elevation elicited by BzATP. In addition, inhibition of phosphatidylinositol 3-kinase blocked the maintenance but not initiation of the sustained phase. Taken together, we conclude that brief activation of P2X₇ receptors on osteoblast-like cells triggers a dramatic, Ca²⁺-dependent stimulation of metabolic acid production. This increase in proton efflux is sustained and dependent on glucose and phosphatidylinositol 3-kinase activity.
Similar articles
-
Osteoblast responses to nucleotides increase during differentiation.Bone. 2006 Aug;39(2):300-9. doi: 10.1016/j.bone.2006.02.063. Epub 2006 Apr 17. Bone. 2006. PMID: 16616882
-
Receptor-independent effects of 2'(3')-O-(4-benzoylbenzoyl)ATP triethylammonium salt on cytosolic pH.Purinergic Signal. 2013 Dec;9(4):687-93. doi: 10.1007/s11302-013-9365-4. Epub 2013 May 22. Purinergic Signal. 2013. PMID: 23689980 Free PMC article.
-
Caveolin-1 regulates P2X7 receptor signaling in osteoblasts.Am J Physiol Cell Physiol. 2015 Jan 1;308(1):C41-50. doi: 10.1152/ajpcell.00037.2014. Epub 2014 Oct 15. Am J Physiol Cell Physiol. 2015. PMID: 25318104 Free PMC article.
-
Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.Channels (Austin). 2024 Dec;18(1):2355150. doi: 10.1080/19336950.2024.2355150. Epub 2024 May 19. Channels (Austin). 2024. PMID: 38762911 Free PMC article. Review.
-
[Purinergic P2X family and specific features of the P2X7 subtype].Cesk Fysiol. 2013;62(2):40-6. Cesk Fysiol. 2013. PMID: 24392594 Review. Czech.
Cited by
-
Modeling Interactions among Individual P2 Receptors to Explain Complex Response Patterns over a Wide Range of ATP Concentrations.Front Physiol. 2016 Jul 13;7:294. doi: 10.3389/fphys.2016.00294. eCollection 2016. Front Physiol. 2016. PMID: 27468270 Free PMC article.
-
Electromagnetic field treatment increases purinergic receptor P2X7 expression and activates its downstream Akt/GSK3β/β-catenin axis in mesenchymal stem cells under osteogenic induction.Stem Cell Res Ther. 2019 Dec 21;10(1):407. doi: 10.1186/s13287-019-1497-1. Stem Cell Res Ther. 2019. PMID: 31864409 Free PMC article.
-
Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation.Purinergic Signal. 2018 Sep;14(3):299-305. doi: 10.1007/s11302-018-9610-y. Epub 2018 May 12. Purinergic Signal. 2018. PMID: 29754194 Free PMC article.
-
P2X7Rs: new therapeutic targets for osteoporosis.Purinergic Signal. 2023 Mar;19(1):207-219. doi: 10.1007/s11302-021-09836-0. Epub 2022 Feb 2. Purinergic Signal. 2023. PMID: 35106736 Free PMC article. Review.
-
The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.Sci Rep. 2017 Oct 10;7(1):12917. doi: 10.1038/s41598-017-13300-8. Sci Rep. 2017. PMID: 29018292 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous